JNP Medi, Appoints Kim Se-eun as Executive Director of Clinical Services Expert

JNP Medi announced on the 24th that it has recruited Executive Director Kim Se-eun to streamline clinical services and enhance quality.

Kim Se-eun, Executive Director at JNP Medi [Photo by JNP Medi]

Executive Director Kim graduated from the Department of Nursing at Ewha Womans University and earned a master's degree in Health Policy from Seoul National University Graduate School of Public Health. She began her career at the Clinical Trial Center of Samsung Seoul Hospital. Afterwards, she gained practical experience in various fields such as clinical trial operations, data management, and quality control at LSK Global PS, a contract research organization (CRO). As a director of business development, she acquired experience and capabilities in proposing optimal solutions to clinical trial sponsors through exchanges with various domestic and international pharmaceutical, bio companies, and CROs.

Through the addition of Executive Director Kim, JNP Medi plans to integrate Maven CDMS, Maven Builder, and the Maven Clinical Cloud into overall clinical services to further advance data and operational management processes, strengthen quality, and accelerate clinical services toward digital transformation (DX).

Jung Kwon-ho, CEO of JNP Medi, said, "Executive Director Kim Se-eun will play a key role in planning and presenting solutions that meet the diverse needs of clients based on her extensive experience and insights in the industry. We also expect her to greatly contribute to setting the company’s future direction and promoting Korea’s clinical trial systems and technologies overseas."